Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Clin Genet. 2015 Feb 26;88(6):523–529. doi: 10.1111/cge.12563

Table 5.

Frequencies of actions and combined actions taken upon receiving a reclassified VUS result.

VUS reclassified as deleterious (n = 308*) Frequency
(percent)
VUS reclassified as benign (n = 345*) Frequency
(percent)
Actions taken with the patient

Call only 10 (3.25%) Call only 24 (6.96%)
Face-to-Face only 16 (5.19%) Face-to-Face only 2 (0.58%)
Call + Mail 71 (23.05%) Call + Mail 232 (67.25%)
Call + Face-to-Face 32 (10.39%) Call + Face-to-Face 15 (4.35%)
Mail+ Face-to-Face 11 (3.57%) Mail+ Face-to-Face 3 (0.87%)
Call + Mail + Face-to-Face 167 (54.22%) Call + Mail + Face-to-Face 34 (9.86%)
None of these 1 (0.32%) None of these 2 (0.58%)

Actions taken with other healthcare providers

Letter only 29 (9.42%) Letter only 29 (8.41%)
Results only 21 (29.87%) Results Only 29 (8.41%)
Letter + Results 166 (53.90%) Letter + Results 192 (55.65%)
None of these 92 (29.87%) None of These 95 (27.54%)
*

Note: Only those who reported experience with VUS reclassification were included in this analysis.